[
  {
    "objectID": "scicom.html",
    "href": "scicom.html",
    "title": "Scientific Committee",
    "section": "",
    "text": "How to get on the scientific committee\nPrinciples for joining the Scientific Committee have been outlined by EFSPI workshop leadership in this slidedeck.\n\n\nMembers\n\n202420232022\n\n\nIn 2024 the members of the scientific committee are (for regulators countries in parentheses):\n\n\n\n\n\n\n\n\n\n\n\n\nFirst\nLast\nGender\nType\nAffiliation\n\n\n\n\nJenny\nDevenport\nf\nIndustry\nRoche\n\n\nJulie\nJones\nf\nIndustry\nNovartis\n\n\nHelle\nLynggaard\nf\nIndustry\nNovo Nordisk\n\n\nEgbert\nBiesheuvel\nm\nIndustry\nViatris\n\n\nHans Ulrich\nBurger\nm\nIndustry\nRoche\n\n\nKaspar\nRufibach\nm\nIndustry\nRoche\n\n\nEmmanuel\nZuber\nm\nIndustry\nNovartis\n\n\nElina\nAsikanius\nf\nRegulator\nFIMEA (Finland)\n\n\nCorine\nBaayen\nf\nIndustry\nFerring\n\n\nVivian\nLanius\nf\nIndustry\nBayer\n\n\nBergrun Tina\nMagnusdottir\nf\nRegulator\nIcelandic Medicines Agency (Iceland)\n\n\nHeidi\nMestl\nf\nRegulator\nLegemiddelverket (Norway)\n\n\nEftychia Eirini\nPsarelli\nf\nRegulator\nEMA\n\n\nKhadija\nRantell\nf\nRegulator\nMHRA (UK)\n\n\nGiulia\nZigon\nf\nIndustry\nGSK\n\n\nLukas\nAguirre Davila\nm\nRegulator\nPaul-Ehrlich Institute (Germany)\n\n\nAndreas\nBrandt\nm\nRegulator\nBfARM (Germany)\n\n\nAnders\nGorst-Rasmussen\nm\nIndustry\nNovo Nordisk\n\n\nBenjamin\nHofner\nm\nRegulator\nPaul-Ehrlich Institute (Germany)\n\n\nWolfgang\nJacquet\nm\nRegulator\nFAMHP (Belgium)\n\n\nFlorian\nKlinglmueller\nm\nRegulator\nAGES (Austria)\n\n\nPierre\nMancini\nm\nIndustry\nSanofi\n\n\nFredrik\nOehrn\nm\nIndustry\nJ&J\n\n\nKit\nRoes\nm\nRegulator\nCBG (Netherlands)\n\n\nDavid\nWright\nm\nIndustry\nAstraZeneca\n\n\n\n\n\nIn 2024 we also had a committee that contributed to the planning of HTA talks.\n\n\n\n\n\nFirst\nLast\nGender\nType\nAffiliation\n\n\n\n\nLilla\nDi Scala\nf\nIndustry\nJ&J\n\n\nKatrin\nKupas\nf\nIndustry\nBMS\n\n\nAntonia\nMorga\nf\nIndustry\nAstellas\n\n\nAnders\nGorst-Rasmussen\nm\nIndustry\nNovo Nordisk\n\n\nSandro\nGsteiger\nm\nIndustry\nRoche\n\n\nFrancois\nMaignen\nm\nHTA\nNICE UK\n\n\n\n\n\n\n\nIn 2023 the members of the scientific committee were (for regulators countries in parentheses):\n\n\n\n\n\n\n\n\n\n\n\n\nFirst\nLast\nGender\nType\nAffiliation\n\n\n\n\nElina\nAsikanius\nF\nRegulator\nFIMEA (Finland)\n\n\nEftychia-Eirini\nPsarelli\nF\nRegulator\nEMA\n\n\nKhadija\nRantell\nF\nRegulator\nMHRA (UK)\n\n\nLukas\nAguirre Dávila\nM\nRegulator\nPaul-Ehrlich Institute (Germany)\n\n\nAndreas\nBrandt\nM\nRegulator\nBfARM (Germany)\n\n\nLorenzo\nHess\nM\nRegulator\nSwissmedic (Switzerland)\n\n\nBenjamin\nHofner\nM\nRegulator\nPaul-Ehrlich Institute (Germany)\n\n\nWolfgang\nJacquet\nM\nRegulator\nFAMHP (Belgium)\n\n\nAndreas\nKirisits\nM\nRegulator\nAGES\n\n\nFlorian\nKlinglmueller\nM\nRegulator\nAGES (Austria)\n\n\nArmin\nKoch\nM\nRegulator\nEMA\n\n\nKit\nRoes\nM\nRegulator\nCBG (Netherlands)\n\n\nFerran\nTorres\nM\nRegulator\nAEMPS (Spain)\n\n\nCorine\nBaayen\nF\nIndustry\nLundbeck\n\n\nRandi\nGrøn\nF\nIndustry\nNovo Nordisk\n\n\nVivian\nLanius\nF\nIndustry\nBayer\n\n\nHelle\nLynggaard\nF\nIndustry\nNovo Nordisk\n\n\nGiulia\nZigon\nF\nIndustry\nGSK\n\n\nEgbert\nBisheuvel\nM\nIndustry\nViatris\n\n\nHans Ulrich\nBurger\nM\nIndustry\nRoche\n\n\nChristoph\nGerlinger\nM\nIndustry\nBayer\n\n\nFredrik\nÖhrn\nM\nIndustry\nJ&J\n\n\nKaspar\nRufibach\nM\nIndustry\nRoche\n\n\nDavid\nWright\nM\nIndustry\nAstraZeneca\n\n\nEmmanuel\nZuber\nM\nIndustry\nNovartis\n\n\nAnja\nSchiel\nF\nHTA/Regulator\nLegemiddelverket (Norway)\n\n\nMaignen\nFrancois\nM\nHTA\nNICE\n\n\n\n\n\n\n\nIn 2022 the members of the scientific committee were:\n\n\n\n\n\n\n\n\n\n\n\n\nFirst\nLast\nGender\nType\nAffiliation\n\n\n\n\nElina\nAsikanius\nf\nRegulator\nFinnish Medicines Agency\n\n\nEftychia Eirini\nPsarelli\nf\nRegulator\nEMA\n\n\nKhadija\nRantell\nf\nRegulator\nMHRA\n\n\nAnja\nSchiel\nf\nRegulator\nNorwegian Medicine Agency\n\n\nAndreas\nBrandt\nm\nRegulator\nBfArM\n\n\nLorenzo\nHess\nm\nRegulator\nSwissmedic\n\n\nArmin\nKoch\nm\nRegulator\nMedizinische Hochschule Hannover\n\n\nKit\nRoes\nm\nRegulator\nRadboud UMC\n\n\nRandi\nGrøn\nf\nIndustry\nNovo Nordisk\n\n\nHelle\nLynggaard\nf\nIndustry\nNovo Nordisk\n\n\nViktoriya\nStalbovskaya\nf\nIndustry\nMerus\n\n\nEgbert\nBiesheuvel\nm\nIndustry\nViatris\n\n\nHans Ulrich\nBurger\nm\nIndustry\nRoche\n\n\nChristoph\nGerlinger\nm\nIndustry\nBayer\n\n\nKaspar\nRufibach\nm\nIndustry\nRoche\n\n\nDavid\nWright\nm\nIndustry\nAstraZeneca\n\n\nEmmanuel\nZuber\nm\nIndustry\nNovartis\n\n\n\n\n\nSee also the program of 2022.\n\n\n\n\n\nQuestions?\nFor feedback and questions send an email to info@efspiworkshop.org."
  }
]